Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7276 p700
22 November 2003

This article
Reprint
Photocopy


News summary


New regulation council opposes NHS proposals to create blame-free culture

Patient safety and the need for professionals to report incidents and to learn from them have to be balanced

Opposition to Department of Health proposals intended to create a blame-free culture in the National Health Service, in order promote error reporting and more rapid redress for patients who suffer harm, is being mounted by the Council for the Regulation of Healthcare Professionals.

In a response to proposals set out by chief medical officer Sir Liam Donaldson earlier this year (PJ, 5 July, p8), the CRHP rejects the suggestion that health professionals who own up to mistakes, except where a criminal offence has been committed, should be given exemption from disciplinary action, as it argues it would not be safe to allow the individual to continue in professional practice.

The council says that the proposal is misconceived and contrary to the demands of public safety. Although it recognises that the motive behind the proposal is to remove disincentives to report adverse incidents honestly, the council says that public protection must take priority. “We suspect that the real barrier to candour is a management climate of fear and the perceived risk of rushed exemplary suspension or dismissal, rather than the possibility of regulatory action, involving a fair hearing with a right of representation,” the CRHP says. “We do recognise that professionals may also be afraid of being reported to their regulator, but in our view employers and regulators must be able to take action to protect patients when ‘the system’ knows that there has been a serious failure.”

The council also opposes a proposal that incident reports should be legally privileged. It says: “An adverse incident report is part of the patient’s clinical history and it seems a retrograde step to prevent the patient from seeing it. The idea that information for a court hearing needs to be collected afresh adds to, rather than helps to resolve, the current problem that different dispute resolution processes are perceived as [being] unable to use the same evidence, with resulting delays and duplication.”

It adds that regulatory bodies would expect to be able to use such reports in fitness to practise procedures and that some have an explicit legal power to obtain them for that purpose. There may also be problems of the compatibility of this recommendation with the Data Protection Act and Article 6 of the European Convention on Human Rights.

A spokesman for the Department of Health said in response to CRHP’s rejection of the suggestion that health professionals who own up to mistakes should be given exemption from disciplinary action: “This was just one issue raised as part of the consultation document ‘Making amends’. Health care regulatory bodies have been, and remain part of, this consultation and the subesequent policy development process.”

Comment, p698

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal